We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-2.27%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$4.04B
AUM Growth
-$461M
Cap. Flow
-$296M
Cap. Flow %
-7.33%
Top 10 Hldgs %
53.79%
Holding
85
New
5
Increased
13
Reduced
30
Closed
9

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$83.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SINA
Sina Corp
SINA
+$45.9M
4
GILD icon
Gilead Sciences
GILD
+$19.4M
5
SWKS icon
Skyworks Solutions
SWKS
+$16M

Top Sells

Rank Stock Value
1
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
+$76.3M
2
KBR icon
KBR
KBR
+$37.7M
3
GLW icon
Corning
GLW
+$35.4M
4
AMFW
AMEC Foster Wheeler plc
AMFW
+$29.9M
5
KO icon
Coca-Cola
KO
+$29.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.34%
2 Technology 18.33%
3 Communication Services 17.23%
4 Industrials 11.46%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MU icon
51
Micron Technology
MU
$981B
$2.22M 0.06%
161,700
-729,000
-82% -$8.29M
AERI
52
DELISTED
Aerie Pharmaceuticals
AERI
$2.15M 0.05%
122,000
– –
ICLR icon
53
Icon
ICLR
$12.6B
$2M 0.05%
28,500
– –
ARIA
54
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.85M 0.05%
250,300
– –
SGEN
55
DELISTED
Seagen Inc. Common Stock
SGEN
$1.69M 0.04%
41,800
+7,800
+23% +$297K
PFE icon
56
Pfizer
PFE
$151B
$1.68M 0.04%
50,181
– –
PRTA icon
57
Prothena Corp
PRTA
$453M
$1.4M 0.03%
+40,000
New +$1.74M
BMRN icon
58
BioMarin Pharmaceuticals
BMRN
$12.2B
$1.34M 0.03%
17,220
– –
GRPN icon
59
Groupon
GRPN
$979M
$1.32M 0.03%
20,350
– –
CFMS
60
DELISTED
Conformis, Inc. Common Stock
CFMS
$1.28M 0.03%
7,282
+2,802
+63% +$659K
ACAD icon
61
Acadia Pharmaceuticals
ACAD
$4.99B
$1.24M 0.03%
38,300
-7,700
-17% -$258K
LIVN icon
62
LivaNova
LIVN
$4.15B
$1.2M 0.03%
23,982
– –
CAH icon
63
Cardinal Health
CAH
$55.8B
$1.09M 0.03%
14,000
– –
MRK icon
64
Merck
MRK
$317B
$1.08M 0.03%
19,702
– –
EMC
65
DELISTED
EMC CORPORATION
EMC
$1.03M 0.03%
38,000
– –
BIIB icon
66
Biogen
BIIB
$30.4B
$967K 0.02%
4,000
– –
RTX icon
67
RTX Corp
RTX
$300B
$820K 0.02%
12,712
– –
INFI
68
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$662K 0.02%
498,232
+291,300
+141% +$1.36M
MRUS
69
DELISTED
Merus
MRUS
$559K 0.01%
+70,000
New +$612K
JOBS
70
DELISTED
51job Inc
JOBS
$449K 0.01%
15,336
– –
VECO icon
71
Veeco
VECO
$3.18B
$414K 0.01%
25,000
– –
ATHM icon
72
Autohome
ATHM
$2.62B
$281K 0.01%
14,000
– –
IMGN
73
DELISTED
Immunogen Inc
IMGN
$279K 0.01%
90,600
– –
META icon
74
Meta Platforms (Facebook)
META
$1.51T
$221K 0.01%
1,940
– –
AMFW
75
DELISTED
AMEC Foster Wheeler plc
AMFW
$195K ﹤0.01%
29,908
-4,580,802
-99% -$29.9M
1 2
3
4

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Platinum Investment Management held 85 positions worth $4.04B, down 10% from $4.5B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Platinum Investment Management withdrew a net $296M in Q2 2016, closing 9 positions and reducing 30 holdings. Its most notable exit was QLIK TECHNOLOGIES INC COM STK (DE), an estimated $76.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 18% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Platinum Investment Management opened a new position in Alibaba worth $84.4M.

  • Platinum Investment Management's largest Q2 2016 buy was Alibaba: 1,061,322 shares worth $84.4M.
  • Platinum Investment Management added most to Johnson & Johnson in Q2 2016, an estimated $58.3M increase.
  • Platinum Investment Management's biggest Q2 2016 reduction was KBR, cutting an estimated $37.7M.
  • Platinum Investment Management fully exited QLIK TECHNOLOGIES INC COM STK (DE) in Q2 2016, selling an estimated $76.3M.
  • Platinum Investment Management's ten largest holdings make up 54% of its $4.04B portfolio in Q2 2016.
  • Platinum Investment Management opened 5 new positions and closed 9 in Q2 2016.
  • Platinum Investment Management's portfolio value fell 10% quarter-over-quarter to $4.04B.

Based on Platinum Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.